Video analysis of interaction in schizophrenia reveals functionally relevant abnormalities

2024-12-1

Hybrid mHealth care: Patient perspectives of blended treatments for psychosis. A systematic review

2024-12-1

Obsessive-compulsive symptoms in individuals at clinical high risk for psychosis: A 2-year longitudinal study

2024-12-1

Hallucinations and the depth-inversion illusion in schizophrenia

2024-12-1

Relations between changes in safety behavior, paranoid ideations, cognitive biases, and clinical characteristics of patients with a psychotic disorder over time

2024-10-1

Disturbance at the self-other boundary in schizophrenia: Linking phenomenology to clinical neuroscience

2024-10-1

Are factors that predict conversion to psychosis associated with initial transition to a high risk state? An adolescent brain cognitive development study analysis

2024-10-1

Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data

2024-10-1

Self and time in individuals with schizophrenia: A motor component?

2024-10-1

Upregulated solute-carrier family genes in the hippocampus of schizophrenia can be rescued by antipsychotic medications

2024-10-1

Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition

2024-10-1

Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia

2024-10-1

Ontogenesis of self-disorders in the schizophrenia spectrum: A phenomenological neuro-developmental model

2024-10-1

Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis

2024-10-1

Examining measures of schizotypy for gender and racial bias using item response theory and differential item functioning

2024-10-1

Atypical presentation of schizophrenia with ablution avoidance: A case report

2024-10-1

Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms

2024-10-1

What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services?

2024-10-1

Recognition of schizophrenia and quality of treatment during the COVID-19 pandemic: A Danish nationwide study

2024-9-14

Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia

2024-9-14

Issue highlights

2024-9-12

Editorial Board

2024-9-12

Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review

2024-9-11

Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction model

2024-9-10

The neuromuscular basis of functional impairment in schizophrenia: A scoping review

2024-9-10

Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials

2024-9-10

Analysis of the complement component C4 gene with schizophrenia subphenotypes

2024-9-1

Altered lipidomics biosignatures in schizophrenia: A systematic review

2024-9-1

Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience

2024-9-1

Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure

2024-9-1

Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis

2024-9-1

Issue highlights

2024-9-1

Editorial Board

2024-9-1

Does relapse cause illness progression in first-episode psychosis? A review

2024-9-1

Deciphering language disturbances in schizophrenia: A study using fine-tuned language models

2024-9-1

Corrigendum to “The danger of averages in the context of heterogeneity: Response to the letter to the editor of SCZ RES - role of ECT in patients with CRS - Markota et al., 2024” [Schizophr. Res. 269 (2024): 120–122]

2024-9-1

The association of tobacco smoking and metabolite levels in the anterior cingulate cortex of first-episode psychosis patients: A case-control and 6-month follow-up 1H-MRS study

2024-9-1

Visual contrast sensitivity in clinical high risk and first episode psychosis

2024-9-1

Mechanisms mediating ethnoracial discrimination and suspiciousness in Asian, Black, and Hispanic United States college students

2024-9-1

Philosophy in psychiatry: Sparking a renaissance of individuality- authors reply to the comment of Trino and Laura Baptista

2024-9-1

Increased COVID-19 mortality in patients with schizophrenia: A retrospective study in Brazil

2024-9-1

Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts

2024-9-1

Neurocognition in adolescents and young adults at clinical high risk for psychosis: Predictive stability for social and role functioning

2024-9-1

Astrocytic contributions to clozapine response: Potential support for a psychopharmacologic glial process

2024-9-1

Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder

2024-9-1

Early cognitive development and psychopathology in children at familial high risk for schizophrenia

2024-9-1

Aggressive behaviors in first-episode psychosis: Distinction between the premorbid phase and the onset of psychosis

2024-9-1

NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia

2024-9-1

Behind the heterogeneity in the long-term course of first-episode psychosis: Different psychotic symptom trajectories are associated with different patterns of cannabis and stimulant use

2024-9-1

Altered brain and physiological stress responses in early psychosis

2024-9-1